瑞士关于糖尿病患者驾驶能力的建议
Roger Lehmann1, Sandrina Bervini2, Vojtech Pavlicek3
1Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
大多数患有糖尿病的司机可以安全驾驶汽车. 新的持续血糖监测系统 (CGMS) 降低了低血糖风险,改善了糖尿病司机的道路安全.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病管理 糖尿病管理
- 道路交通安全 道路交通安全
背景情况:
- 仅仅诊断出糖尿病是不足以确定驾驶安全的.
- 与糖尿病相关的事故很少见,并且比其他损害性疾病更少发生.
- 诸如低血糖症,严重视网膜病变或神经病变等并发症的发生率不足以限制所有糖尿病驾驶员.
研究的目的:
- 评估现代糖尿病管理技术对驾驶安全的影响.
- 重新评估糖尿病患者的驾驶建议.
- 探索持续葡萄糖监测系统 (CGMS) 在减轻驾驶风险方面的作用.
主要方法:
- 对持续葡萄糖监测系统 (CGMS) 数据进行分析,以客观地评估低血糖.
- 审查糖尿病护理的近期药理和技术进步.
- 与各种糖尿病治疗相关的风险和它们对驾驶的影响的比较.
主要成果:
- 现代治疗2型糖尿病的方法 (除了胰岛素) 不会导致低血糖;超长效胰岛素的风险较低.
- 结合混合闭环胰岛素的CGMS显著减少低血糖事件和血糖波动.
- CGMS使客观的低血糖评估成为可能,提高了道路安全,并为驾驶员降低了血糖安全边际.
结论:
- 连续血糖监测系统 (CGMS) 提高了糖尿病患者的道路安全,包括那些怀孕期糖尿病或怀孕期间.
- 像CGMS这样的技术进步允许更准确的风险评估,并可能允许某些患者获得更高的车辆许可证类别.
- 使用CGMS使得驾驶员不需要频繁的车载血糖监测.
更多相关视频
11:12Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
